Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study

被引:52
|
作者
Hamed, Enas A. [1 ]
ElMelegy, Nagla T. [2 ]
机构
[1] Assiut Univ, Fac Med, Dept Physiol, Assiut, Egypt
[2] Assiut Univ, Fac Med, Dept Biochem, Assiut, Egypt
关键词
SERUM CYSTATIN-C; GLOMERULAR-FILTRATION-RATE; ANTIOXIDANT CAPACITY; KIDNEY-FUNCTION; IRON OVERLOAD; EARLY MARKERS; CHILDREN; DYSFUNCTION; DEFEROXAMINE; DISEASE;
D O I
10.1186/1824-7288-36-39
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: In beta-thalassemia, profound anemia and severe hemosiderosis cause functional and physiological abnormalities in various organ systems. In recent years, there have been few published studies mainly in adult demonstrating renal involvement in beta-thalassemia. This prospective study was aimed to investigate renal involvement in pediatric patients with transfusion dependant beta-thalassemia major (TD-beta TM), using both conventional and early markers of glomerular and tubular dysfunctions, and to correlate findings to oxidative stress and iron chelation therapy. Methods: Sixty-nine TD-beta TM patients (aged 1-16 years) and 15 healthy controls (aged 3-14 years) were enrolled in this study. Based on receiving chelation therapy (deferoxamine, DFO), patients were divided into two groups: group [I] with chelation (n = 34) and group [II] without chelation (n = 35). Levels of creatinine (Cr), calcium (Ca), inorganic phosphorus (PO4), uric acid (UA) and albumin were measured by spectrophotometer. Serum (S) levels of cystatin-C (S-CysC) and total antioxidant capacity (S-TAC) and urinary (U) levels of beta(2)-microglobulin (U-beta 2MG) were measured by immunosorbent assay (ELISA). Urinary N-acetyl-beta-D-glucosaminidase (U-NAG) activity and malondialdehyde (U-MDA) were measured by chemical methods. Estimated glomerular filtration rate (eGFR) was determined from serum creatinine. Results: In patient with and without chelation, glomerular [elevated SCysC, SCr, Ualbumin/Cr and diminished eGFR]; and tubular dysfunctions [elevated S-UA, S-PO4, U-NAG/Cr, U-beta 2MG/Cr] and oxidative stress marker disturbances [diminished S-TAC and elevated U-MDA/Cr] were reported than controls. In patients with chelation, S-CysC was significantly higher while, S-TAC was significantly lower than those without chelation. In all patients, S-CysC showed significant positive correlation with S-Cr and negative correlation with eGFR; S-TAC showed significant positive correlation with eGFR and negative correlation with S-CysC, S-Cr, U-NAG/Cr; U-MDA/Cr showed significant positive correlation with U-albumin/Cr, U-beta 2MG/Cr, U-NAG/Cr. Conclusions: Our data confirm high frequency of glomerular and tubular dysfunctions in TD-beta TM pediatric patients which could be attributed to oxidative stress and DFO therapy.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study
    Enas A Hamed
    Nagla T ElMelegy
    [J]. Italian Journal of Pediatrics, 36
  • [2] Hypoparathyroidism in children with beta-thalassemia major and its relation to iron chelation therapy
    El-Din, Lerine Bahy
    Ebeid, Fatma S. E.
    Toaima, Nadin N.
    Ibrahim, Walaa W.
    [J]. EGYPTIAN JOURNAL OF HAEMATOLOGY, 2018, 43 (02): : 63 - 68
  • [3] Renal Tubular Dysfunction in Pediatric Patients with beta-Thalassemia Major
    Ahmadzadeh, A.
    Assar, S.
    [J]. PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1822 - 1822
  • [4] Renal Tubular Dysfunction in Pediatric Patients with Beta-thalassemia Major
    Ahmadzadeh, Ali
    Jalali, Amir
    Assar, Shiedeh
    Khalilian, Hamid
    Zandian, Khamorad
    Pedram, Mohammad
    [J]. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2011, 22 (03) : 497 - 500
  • [5] Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox
    Economou, Marina
    Printza, Nikoletta
    Teli, Aikaterini
    Tzimouli, Vassiliki
    Tsatra, Ioanna
    Papachristou, Fotis
    Athanassiou-Metaxa, Miranda
    [J]. ACTA HAEMATOLOGICA, 2010, 123 (03) : 148 - 152
  • [6] Renal function in transfusion-dependent pediatric beta-thalassemia major patients
    Jalali, Amir
    Khalilian, Hamid
    Ahmadzadeh, Ali
    Sarvestani, Somie
    Rahim, Fakher
    Zandian, Khodamorad
    Asar, Shideh
    [J]. HEMATOLOGY, 2011, 16 (04) : 249 - 254
  • [7] Beta-Thalassemia Major: A Pediatric Neuropsychological Case Study
    Greco, S.
    Inselberg, M.
    Klimik, L.
    Heptig, M.
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2017, 32 (06)
  • [8] PEDIATRIC THALASSEMIA MAJOR PATIENTS : PROSPECTIVE COMPARISON OF CHELATION TREATMENTS
    Pitrolo, L.
    Meloni, A.
    Gamberini, M. R.
    Casini, T.
    Campisi, S.
    Filati, G.
    Izzi, G.
    Commendatore, F. V.
    Renne, S.
    Pepe, A.
    [J]. HAEMATOLOGICA, 2014, 99 : 444 - 445
  • [9] CHELATION THERAPY IN BETA-THALASSEMIA MAJOR .1. INTRAVENOUS AND SUBCUTANEOUS DEFEROXAMINE
    GRAZIANO, JH
    MARKENSON, A
    MILLER, DR
    CHANG, H
    BESTAK, M
    MEYERS, P
    PISCIOTTO, P
    RIFKIND, A
    [J]. JOURNAL OF PEDIATRICS, 1978, 92 (04): : 648 - 652
  • [10] PATIENTS WITH BETA-THALASSEMIA MAJOR
    NASSERALLAH, Z
    [J]. SAUDI MEDICAL JOURNAL, 1995, 16 (01) : 13 - 16